Accelerated UK Clinical Trial Reforms: Enhancin...

By HEOR Staff Writer

November 5, 2025

UK Clinical Trial Reforms Slash Approval Times UK Clinical Trial Reforms have accelerated clinical trial approvals, reducing average times from 91 days to 41 days through risk-proportio...
Antidepressant Side Effects: New Insights on Cardiometabolic Health Risks
AI Chatbot Delusions: Navigating the Risks of Validation in Mental Health
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
Navigating Novo Nordisk Board Changes: Leadership for Growth and Strategy
Keytruda Lung Cancer Treatment: Long-Term Survival Gains in NSCLC
Cabotegravir HIV Prevention: First Injectable PrEP Recommended for High-Risk ...
Social Media Policy Action: Protecting Youth from Cognitive Risks
Johnson & Johnson Advances Solid Tumor Research at ESMO 2025 with Promis...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...